Literature DB >> 8699144

Circulating levels of IGF-I and IGF-binding protein-1 throughout pregnancy: relation to birthweight and maternal weight.

F A Hills1, J English, T Chard.   

Abstract

Serum levels of IGF-I and IGF-binding protein (IGFBP-1) have been determined in the maternal circulation between 11 and 42 weeks of gestation in women not in labour (n = 335) and in the maternal and fetal circulations at the time of delivery between 37 and 42 weeks (n = 55). Maternal serum (MS) IGF-I levels increased during pregnancy and showed a significant positive correlation with maternal weight (P = 0.0033) but no correlation with birthweight. The MS IGFBP-1 levels did not change during the second and third trimesters and showed a negative correlation with birthweight, maternal weight, placental weight and MS glucose (P = 0.0002, P < 0.0001, P = 0.047, P = 0.024 respectively). MS IGFBP-1 levels were higher in small-for-gestational age babies than in average-for-gestational weight babies (P = 0.026) and lower in the large-for-gestational weight group (P = 0.048). There was a significant rise in mean MS IGFBP-1 levels during labour (P = 0.0005). These findings suggest that IGFBP-1 may be an important factor in pathological growth retardation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8699144     DOI: 10.1677/joe.0.1480303

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  15 in total

1.  Low birthweight and adult insulin resistance: the "catch-up growth" hypothesis.

Authors:  S Cianfarani; D Germani; F Branca
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1999-07       Impact factor: 5.747

2.  The maternal plasma proteome changes as a function of gestational age in normal pregnancy: a longitudinal study.

Authors:  Roberto Romero; Offer Erez; Eli Maymon; Piya Chaemsaithong; Zhonghui Xu; Percy Pacora; Tinnakorn Chaiworapongsa; Bogdan Done; Sonia S Hassan; Adi L Tarca
Journal:  Am J Obstet Gynecol       Date:  2017-03-03       Impact factor: 8.661

3.  Maternal insulin-like growth factor binding protein-1, body mass index, and fetal growth.

Authors:  R P Holmes; J M Holly; P W Soothill
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2000-03       Impact factor: 5.747

4.  The role and regulation of IGFBP-1 phosphorylation in fetal growth restriction.

Authors:  Madhulika B Gupta
Journal:  J Cell Commun Signal       Date:  2015-02-15       Impact factor: 5.782

Review 5.  Novel roles of mechanistic target of rapamycin signaling in regulating fetal growth†.

Authors:  Madhulika B Gupta; Thomas Jansson
Journal:  Biol Reprod       Date:  2019-04-01       Impact factor: 4.285

6.  IUGR Is Associated With Marked Hyperphosphorylation of Decidual and Maternal Plasma IGFBP-1.

Authors:  Madhulika B Gupta; Majida Abu Shehab; Karen Nygard; Kyle Biggar; Sahil S Singal; Nanette Santoro; Theresa L Powell; Thomas Jansson
Journal:  J Clin Endocrinol Metab       Date:  2019-02-01       Impact factor: 5.958

7.  Dysregulation of the interleukin-17A pathway in endometrial tissue from women with unexplained infertility affects pregnancy outcome following assisted reproductive treatment.

Authors:  D A Crosby; L E Glover; E P Brennan; P Kelly; P Cormican; B Moran; F Giangrazi; P Downey; E E Mooney; B J Loftus; F M McAuliffe; M Wingfield; C O'Farrelly; D J Brennan
Journal:  Hum Reprod       Date:  2020-08-01       Impact factor: 6.918

Review 8.  Impact of maternal under nutrition on obstetric outcomes.

Authors:  S Triunfo; A Lanzone
Journal:  J Endocrinol Invest       Date:  2014-09-07       Impact factor: 4.256

9.  Insulin-like growth factor-binding protein 1 and 7 concentrations are lower in obese pregnant women, women with gestational diabetes and their fetuses.

Authors:  M Lappas
Journal:  J Perinatol       Date:  2014-07-31       Impact factor: 2.521

10.  Hormonal and metabolic factors associated with variations in insulin sensitivity in human pregnancy.

Authors:  H David McIntyre; Allan M Chang; Leonie K Callaway; David M Cowley; Alan R Dyer; Tatjana Radaelli; Kristen A Farrell; Larraine Huston-Presley; Saeid B Amini; John P Kirwan; Patrick M Catalano
Journal:  Diabetes Care       Date:  2009-10-30       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.